New Pharma Models for a New Healthcare Era

Report
38 Pages
December 2018
Region: Global
Citeline
ID: 4775111

Overview
The entry of technology players into healthcare, alongside empowered consumers and payers’ singular focus on cost-effective outcomes, is forcing change across all of pharma’s traditional functions. Modern pharma needs to build new kinds of relationships, with each other, with tech players, and with healthcare providers and payers.

OVERVIEW

THE REIMAGINING OF HEALTHCARE

Out with the old, in with the new: how pharma is changing along the value chain
Bibliography

CASE STUDIES

Fresenius: integrating care using data
Novo Nordisk: from drugmaker to data collector
Roche: data curator
Sanofi partners for a place in China’s health delivery revolution
LEO Pharma: building trust by putting the patient first
Amgen: from transactional to collaborative
Bibliography

TECHNOLOGY FIRMS ARE REAL COMPETITORS

Big pharma is up against big tech
Tech firms are hiring healthcare talent
Tech is cozying up to payers and providers
Pharma has been slow to see the tech threat
Bibliography

DIGITAL PRODUCTS CAN ENHANCE DRUG PORTFOLIOS

Digital therapeutics may enhance drug portfolios with patient data
Pharma is investing in digital therapeutics
Digital health firms are working with providers
Data-collecting pills to boost outcomes
Proteus Digital Health: turning pharma’s model on its head?
Bibliography

CHALLENGES TO EMBRACING NEW TECHS AND NEW PARTNERS

Do better relationships make money?
The challenges to embracing digital
Bibliography

LESSONS FROM OTHER SECTORS

Focus on what the customer wants
Consultants also take a cross-sectoral view
Bibliography

21ST CENTURY PHARMA: COLLABORATIVE SOLUTION PROVIDERS

Bibliography

APPENDIX

About the author
Scope
Methodology

LIST OF FIGURES

Figure 1: Old vs new pharma business models
Figure 2: Challenges to embracing the digital business model in pharma
Figure 3: All change: pharma’s new look in a patient-centric, digitalized healthcare world

LIST OF TABLES

Table 1: Changes in key pharma activities in the new healthcare landscape
Table 2: Takeaways of case studies illustrating changing business models

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2903EUR$2,995USD£2,486GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14222EUR$14,676USD£12,181GBP

Table of Contents

Related Topics

Related Reports

Digi-Tech Pharma & AI 2024 (London, United Kingdom - May 28-29, 2024)

Healthcare BPO - Global Strategic Business Report

MEWA Health Economics & Outcomes Research Services Market Size and Forecast, Regional Share, Trends, and Growth Opportunity Analysis Coverage: By Service, Service Provider, End User, and Region

Healthcare Contract Management Software - Global Strategic Business Report

Getting Real with Healthcare Data: RWD/RWE Enabling New Models of Research and Care Delivery